Results 161 to 170 of about 22,853 (279)
Abstract Mirvetuximab‐soravtansine (MIRV‐S) is an antibody‐drug conjugate targeting folate receptor alpha (FOLR1). MIRV‐S is approved for the treatment of FOLR1‐positive, platinum‐resistant ovarian carcinoma. Patient eligibility is determined by immunohistochemistry (IHC) using a companion diagnostic (CDx) assay (FOLR1‐2.1, Ventana).
Annika Nasdala +10 more
wiley +1 more source
Efficacy of laparoscopic pelvic denervation in central-type chronic pelvic pain: A multicenter study [PDF]
Busacca, M. +7 more
core +1 more source
An injectable CNC–PNIPAM hydrogel is developed for intrauterine co‐delivery of levonorgestrel and botropase. This platform reprograms uterine natural killer cells toward an immune–tolerant phenotype and enhances endometrial receptivity marker expression. The results demonstrate a promising strategy to counteract endometriosis–associated infertility and
Zhou Liang +9 more
wiley +1 more source
The impact of laparoscopic deep endometriosis surgery on sexual functioning and distress. [PDF]
de Koning R +7 more
europepmc +1 more source
Systemic immune dysregulation in patients experiencing urogynaecological mesh failure
Abstract Objectives This study aimed to investigate the systemic immune landscape in patients experiencing urogynaecological mesh failure. The use of urogynaecological mesh was paused in the UK following an independent safety review that found ~1 in 15 women required removal due to complications. However, the mechanisms underpinning mesh failure remain
Shannon Jamieson +9 more
wiley +1 more source
Fluorescence-guided nerve-sparing surgery for deep endometriosis using indocyanine green. [PDF]
Kanno K +10 more
europepmc +1 more source
Bladder endometriosis, a remarkable resemblance in a monozygotic twin [PDF]
J. J. van Beek
core +1 more source
Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott +7 more
wiley +1 more source
Urogynecological Outcomes After Minimally Invasive Surgery for Deep Endometriosis: A Systematic Review. [PDF]
Mascellino G +10 more
europepmc +1 more source
Deep endometriosis of ileocecum complicated by acute intestinal obstruction: a case report. [PDF]
Slama L +6 more
europepmc +1 more source

